Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios

Rapid Therapeutic Science Laboratories, Inc. (RTSL) Gross Margin (2020 - 2021)

Rapid Therapeutic Science Laboratories' Gross Margin history spans 2 years, with the latest figure at 100.0% for Q4 2021.

  • For Q4 2021, Gross Margin changed N/A year-over-year to 100.0%; the TTM value through Sep 2022 reached 100.0%, up 136748.0%, while the annual FY2021 figure was 62.55%, 2264.0% down from the prior year.
  • Gross Margin for Q4 2021 was 100.0% at Rapid Therapeutic Science Laboratories, roughly flat from 100.0% in the prior quarter.
  • Across five years, Gross Margin topped out at 6725.17% in Q3 2020 and bottomed at 52.83% in Q2 2021.